The therapeutic strategy for obesity-associated Mets and T2DM
focusing on adipose tissue inflammation and lipid disorders
(Sprache: Englisch)
The prevalence of obesity-associated adipose tissue inflammation with metabolic syndrome and T2DM are increasing. The current guidelines recommend the use of metformin-based combination therapy for patients with T2DM. The therapeutic strategy for...
Leider schon ausverkauft
versandkostenfrei
Buch
23.90 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
Produktdetails
Produktinformationen zu „The therapeutic strategy for obesity-associated Mets and T2DM “
Klappentext zu „The therapeutic strategy for obesity-associated Mets and T2DM “
The prevalence of obesity-associated adipose tissue inflammation with metabolic syndrome and T2DM are increasing. The current guidelines recommend the use of metformin-based combination therapy for patients with T2DM. The therapeutic strategy for obesity-associated metabolic syndrome and T2DM, may require the inclusion of anti-inflammatory properties through appropriate drugs. We find an additional effect of metformin and celecoxib that represents a potential novel and powerful new strategy on obesity-associated lipid dysregulation and adipose tissue inflammation.
Bibliographische Angaben
- Autoren: Po-Shiuan Hsieh , Chieh-Hua Lu
- 2017, 52 Seiten, Maße: 22 cm, Kartoniert (TB), Englisch
- Verlag: LAP Lambert Academic Publishing
- ISBN-10: 620219832X
- ISBN-13: 9786202198325
Sprache:
Englisch
Kommentar zu "The therapeutic strategy for obesity-associated Mets and T2DM"
0 Gebrauchte Artikel zu „The therapeutic strategy for obesity-associated Mets and T2DM“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "The therapeutic strategy for obesity-associated Mets and T2DM".
Kommentar verfassen